PHARMACYTE BIOTECH, INC. Cash and Cash Equivalents, Period Increase (Decrease)
PHARMACYTE BIOTECH, INC. (PMCB) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.66 million for the 9-month period ending 2015-01-31, per its 10-Q filed 2015-03-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2015-03-13
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-01-31 was -$196.19K, a 141.89% decline year-over-year.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2014-01-31 was $468.30K, a 4302.15% increase year-over-year.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-10-31 was $190.56K.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-07-31 was $6.74K, a 21.86% decline year-over-year.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $183.58K.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2012 was -$41.48K, a 173.43% decline from fiscal 2011.
- PHARMACYTE BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2011 was $56.48K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2015-01-31 | -$196.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | -$2.66M 10-Q · filed 2015-03-13 | ||
| 2014-10-31 | -$2.46M 10-Q · filed 2014-12-15 | |||
| 2014-01-31 | $468.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $658.86K derived: sum of 2 quarters · filed 2015-03-13 | $665.59K 10-Q · filed 2015-03-13 | $831.56K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-10-31 | $190.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $197.29K 10-Q · filed 2014-12-15 | $363.26K derived: sum of 3 quarters · filed 2014-12-15 | $373.90K derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | $6.74K 10-Q · filed 2013-09-16 | $172.70K derived: sum of 2 quarters · filed 2013-09-16 | $183.34K derived: sum of 3 quarters · filed 2013-09-16 | $181.70K derived: sum of 4 quarters · filed 2013-09-16 |
| 2013-04-30 | $165.97K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $176.61K derived: sum of 2 quarters · filed 2013-07-29 | $174.96K derived: sum of 3 quarters · filed 2013-07-29 | $183.58K 10-K · filed 2013-07-29 |
| 2013-01-31 | $10.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $8.99K derived: sum of 2 quarters · filed 2013-03-26 | $17.61K 10-Q · filed 2013-03-26 | -$5.74K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-10-31 | -$1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | $6.97K 10-Q · filed 2012-12-26 | -$16.38K derived: sum of 3 quarters · filed 2013-09-16 | $8.19K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-07-31 | $8.62K 10-Q · filed 2013-09-16 | -$14.73K derived: sum of 2 quarters · filed 2013-09-16 | $9.84K derived: sum of 3 quarters · filed 2013-09-16 | -$58.73K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | -$23.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $1.22K derived: sum of 2 quarters · filed 2013-07-29 | -$67.35K derived: sum of 3 quarters · filed 2013-07-29 | -$41.48K 10-K · filed 2013-07-29 |
| 2012-01-31 | $24.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | -$44.00K derived: sum of 2 quarters · filed 2013-03-26 | -$18.12K 10-Q · filed 2013-03-26 | $35.46K derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | -$68.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | -$42.70K 10-Q · filed 2012-12-26 | $10.89K derived: sum of 3 quarters · filed 2012-12-26 | $14.51K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | $25.87K 10-Q · filed 2012-09-19 | $79.46K derived: sum of 2 quarters · filed 2012-09-19 | $83.07K derived: sum of 3 quarters · filed 2012-09-19 | $82.53K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | $53.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $57.20K derived: sum of 2 quarters · filed 2012-08-14 | $56.65K derived: sum of 3 quarters · filed 2012-08-14 | $56.48K 10-K · filed 2012-08-14 |
| 2011-01-31 | $3.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | $3.07K derived: sum of 2 quarters · filed 2012-03-21 | $2.90K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | -$547.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | -$716.00 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | -$169.00 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |